My Pitch: "Very important capability, already approved in Europe, up to 6m patients/yr need this. Been in my watch list for a while, now some PII for U.S. approval are coming through. Looking for entry..."

My Pitch: "Sepsis filter. Trial finishing +/- early Q1 2011.
Good product and market conditions."

My Pitch: "Ctso"

My Pitch: "Time to BUY at this price. Market Cap is less than $9M!"

My Pitch: "Ctso
"

My Pitch: "High end medical disposable product that helps docs control inflammation. Approved in 32 countries. 14,000 safe human treatments. FDA evaluating for cardiac surgery with pivotal study likely in 2017. One of the few methods available for helping docs gets control of sepsis patients in the ICU. "

My Pitch: "Good CEO and some innovative products makes CTSO a great long term bet."

My Pitch: "The principle medical device of CTSO is Cytosorb, a bead filter, that effectively removes Cytokines through dialysis. Cytosorb has been shown to reduce multiple organ failure and death in severe sepsis through cytokine reduction.

“An investigational device exemption (IDE) to initiate clinical "

My Pitch: "Jb.
"

My Pitch: "Product is a blood filter that helps save lives in the emergency room. Truly expanding worldwide. Large revenues from sales and grants coming in. Once this moves even a little higher it will run for the next 3 mnths at least! IMO"

My Pitch: "CT SO IS on the cusp if stardom. I have been 4G axing the news reports from their website and the Cytosorbents technology is proven to take the interludes out of the blood stream that causes inflammation leading to death in ICU. I highly recommend a position while they have been under the radar of W"

My Pitch: "Gonna be a Great stock someday. Looks like 2-3 years before the rocket takes off but below 5.00 is a great place to buy."

My Pitch: "Kaboom"